1.230USD0.00%Mkt Cap: —P/E: —2d ago
Synlogic, Inc. does not have significant operations. It was previously engaged in the discovery and development of synthetic biotics to treat metabolic diseases. Synlogic, Inc. is based in Winchester, Massachusetts.
Industry Peers
Biotechnology$139.84BUSDP/E 32.2
$85.11BUSDP/E 20.4
$69.62BUSD
$60.19BUSDP/E 39.1
$45.16BUSDP/E 19.2
$46.01BUSD
$41.76BUSDP/E 66.2
$35.67BUSDP/E 33.2
$32.46BUSDP/E 42.3
$28.53BUSD
$26.14BUSD
$25.79BUSDP/E 16.2
$20.83BUSDP/E 26.3
$19.17BUSDP/E 26.2
$17.03BUSDP/E 20.0
$16.41BUSD
$13.48BUSDP/E 17.1
$13.42BUSDP/E 187.4
$12.87BUSDP/E 264.5
$12.59BUSD
Key Statistics
Company
Market Cap—
Enterprise Value1.88M $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-655.00K $
Revenue/Share—
Last Price1.230 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees1
CountryGB
SectorHealthcare
IndustryBiotechnology
ISINUS87166L1008
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B1.20
EPS (TTM)-0.97
EPS (Forward)—
52W Range
1.200100% of range1.230
52W High1.230 USD
52W Low1.200 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-5.32%
ROA-16.97%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-3.84M $
CapEx (TTM)—
FCF Margin—
FCF Yield—
Net Debt-13.18M $
Net Debt/EBITDA—
Balance Sheet
Debt/Equity—
Current Ratio9.19
Quick Ratio9.02
Book Value/Sh1.027 USD
Cash/Share1.076 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split0.066667:1
Split DateSep 28, 2023
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.—
Float3.65M
Insiders15.65%
Institutions57.55%
Technical
SMA 503.413 (-64.0%)
SMA 2005.562 (-77.9%)
Beta—
S&P 52W Chg20.80%
Avg Vol (30d)2.40K
Avg Vol (10d)330
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—